Cidara Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 401-425 of 798 matching filings.

Per page
25
Current page
17
DEF 14A File 001-36912

DEFINITIVE PROXY STATEMENT

Filing date
28 Apr 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Apr 2021
Reporting date
05 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Apr 2021
Reporting date
05 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Apr 2021
Reporting date
05 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Apr 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Apr 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-228268

424B5

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A filing

Filing date
08 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SC 13G filing

Filing date
05 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-253545

FORM S-8

Filing date
25 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36912

CIDARA THERAPEUTICS, INC. 2020 FORM 10-K

Filing date
25 Feb 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A filing

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

AMENDMENT NO. 3 TO THE SCHEDULE 13G

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .